Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -245.61x is 236% below its 1-year average of -73.02x, near the low end of its 1-year range (-245.61x–-19.31x).
As of the fiscal period ended Friday, March 31, 2023. 236.35% below its 12-month average of -73.02x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2023 (2023-03-31): -245.61x.
INTEREST COVERAGE RATIO
-245.61x
INTEREST COVERAGE RATIO AVG TTM
-73.02x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-236.35%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-3713.88%
vs the sector median at left
Cadrenal Therapeutics, Inc. Common Stock
Market Cap
$3.53M
Interest Coverage Ratio
-245.61x
TTM Avg
-73.02x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.50M
Interest Coverage Ratio
-0.25x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.49M
Interest Coverage Ratio
N/A
TTM Avg
3249.00x
3Y Avg
3249.00x
5Y Avg
3249.00x
Market Cap
$3.63M
Interest Coverage Ratio
-4.96x
TTM Avg
3.26x
3Y Avg
13.21x
5Y Avg
13.21x
Market Cap
$3.65M
Interest Coverage Ratio
-345.15x
TTM Avg
1.19x
3Y Avg
1.19x
5Y Avg
1.19x
Market Cap
$3.30M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.28M
Interest Coverage Ratio
-12.86x
TTM Avg
85.32x
3Y Avg
145.98x
5Y Avg
123.76x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | $3.53M | -245.61x | -73.02x | N/A | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.50M | -0.25x | N/A | N/A | N/A |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A | 3249.00x | 3249.00x | 3249.00x |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.63M | -4.96x | 3.26x | 13.21x | 13.21x |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.65M | -345.15x | 1.19x | 1.19x | 1.19x |
| Evogene Ltd. (EVGN)vs › | $3.65M | -7.42x | N/A | N/A | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | N/A | N/A | N/A | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.28M | -12.86x | 85.32x | 145.98x | 123.76x |
| MBody AI Ltd. (MBAI)vs › | $3.25M | -12.83x | N/A | N/A | N/A |
Interest Coverage
-245.6x
Debt/Equity
0.00
Current Ratio
3.73
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-03-31 | -245.61x |
| 2022-12-31 | -19.31x |
| 2022-09-30 | -30.39x |
| 2022-06-30 | -32.66x |
| 2022-03-31 | -37.16x |
